KoBioLabs, Inc (KOSDAQ:348150)
South Korea
· Delayed Price · Currency is KRW 5,530.00
+70.00 (1.28%)
At close: Dec 5, 2025
KoBioLabs Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | -6,547 | -5,298 | -13,853 | -21,921 | -15,382 | -55,072 | Upgrade
|
| Depreciation & Amortization | 2,772 | 2,578 | 1,515 | 908.06 | 232.72 | 209.89 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 123.43 | - | 6.85 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -146.57 | - | - | -11.51 | -7.33 | - | Upgrade
|
| Stock-Based Compensation | 220.74 | 265.42 | 800.35 | 1,695 | 1,571 | 2,405 | Upgrade
|
| Other Operating Activities | 202.01 | 942.99 | -2,408 | 3,127 | -704.12 | 43,163 | Upgrade
|
| Change in Accounts Receivable | -2,488 | -950.57 | -1,266 | -702.54 | 2,478 | -2,570 | Upgrade
|
| Change in Inventory | -1,709 | -3,202 | -487.87 | -725.03 | -150.65 | 73.85 | Upgrade
|
| Change in Accounts Payable | 347.16 | 2.62 | - | - | - | -68.59 | Upgrade
|
| Change in Unearned Revenue | - | -5.45 | -114.78 | -512.29 | 361.64 | 206.07 | Upgrade
|
| Change in Other Net Operating Assets | 622.51 | 1,188 | 1,982 | 1,580 | -880.97 | -1,118 | Upgrade
|
| Operating Cash Flow | -6,726 | -4,355 | -13,832 | -16,556 | -12,481 | -12,771 | Upgrade
|
| Capital Expenditures | -265.96 | -1,640 | -15,133 | -14,683 | -5,512 | -124.98 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 1.21 | 0.81 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -115.5 | -6.5 | -428.32 | -81.81 | -39.07 | -150.81 | Upgrade
|
| Investment in Securities | 8,628 | 6,113 | 23,960 | -46,421 | -25,454 | 21,294 | Upgrade
|
| Other Investing Activities | 2,035 | 1,967 | -217.46 | -748.86 | -19.09 | -26.33 | Upgrade
|
| Investing Cash Flow | 10,281 | 6,434 | 8,192 | -61,814 | -31,154 | 20,992 | Upgrade
|
| Short-Term Debt Issued | - | 4,800 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 3,200 | 4,000 | 6,059 | 13,346 | - | Upgrade
|
| Total Debt Issued | 9,600 | 8,000 | 4,000 | 6,059 | 13,346 | - | Upgrade
|
| Short-Term Debt Repaid | - | -1,075 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -13,582 | -339.15 | -95.54 | -39.3 | -15.92 | Upgrade
|
| Total Debt Repaid | -13,064 | -14,657 | -339.15 | -95.54 | -39.3 | -15.92 | Upgrade
|
| Net Debt Issued (Repaid) | -3,464 | -6,657 | 3,661 | 5,964 | 13,307 | -15.92 | Upgrade
|
| Issuance of Common Stock | 113.53 | 151.32 | 395.17 | 10,750 | 4,350 | 31,061 | Upgrade
|
| Other Financing Activities | -2,189 | -7.48 | -9.89 | 19,596 | -0 | 0 | Upgrade
|
| Financing Cash Flow | -5,533 | -6,513 | 4,046 | 36,310 | 55,741 | 31,045 | Upgrade
|
| Foreign Exchange Rate Adjustments | 25.51 | 76.26 | 1,208 | -199.67 | -40.36 | 82.39 | Upgrade
|
| Net Cash Flow | -1,952 | -4,358 | -386.23 | -42,260 | 12,066 | 39,348 | Upgrade
|
| Free Cash Flow | -6,992 | -5,995 | -28,966 | -31,239 | -17,993 | -12,896 | Upgrade
|
| Free Cash Flow Margin | -9.73% | -8.77% | -87.41% | -269.17% | -621.88% | -280.86% | Upgrade
|
| Free Cash Flow Per Share | -361.30 | -312.55 | -1563.45 | -1859.88 | -1121.36 | -1202.99 | Upgrade
|
| Cash Interest Paid | 621.72 | 670.65 | 303.02 | 140.63 | 8.88 | 14.53 | Upgrade
|
| Cash Income Tax Paid | - | 15.9 | 249.35 | 239.81 | 180.4 | 56.09 | Upgrade
|
| Levered Free Cash Flow | -6,019 | -11,457 | -20,874 | -24,552 | -16,000 | -90,604 | Upgrade
|
| Unlevered Free Cash Flow | -5,695 | -10,733 | -19,916 | -23,501 | -15,904 | -90,162 | Upgrade
|
| Change in Working Capital | -3,228 | -2,967 | 113.36 | -359.91 | 1,808 | -3,477 | Upgrade
|
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.